VANCOUVER, BC, Jan. 21, 2025 ~ Las Vegas, NV - Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, has made a groundbreaking leap in the field of rehabilitation technology with their latest product, XoMotion™. This innovative medical exoskeleton was recently named the Top Robot at CES 2025 by USA Today.

CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.

The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.

More on nvtip.com

• $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
• Pacsun Joins UFC International Fight Week with Exclusive Collection and First-Ever UFC X Activation
• Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
• Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
• Christina Aldan Announces Website Update Highlighting Massage Therapy Training

Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.

The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.

One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.

For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.

XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.

More on nvtip.com

• Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
• Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
• Intelligent Technical Solutions Appoints Dave Dyas as Senior Vice President of Channels & Alliances
• Wingderm USA Takes the Lead at TAS 2025, Cementing Its Local Presence in the U.S. USA - English USA - English USA - Français USA - Deutsch USA - español
• AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)

Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.

Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.

For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.

---

Show All News | Report Violation